vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Datavault AI Inc. (DVLT). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $33.8M, roughly 1.3× Datavault AI Inc.). Datavault AI Inc. runs the higher net margin — 2.0% vs -23.3%, a 25.2% gap on every dollar of revenue. On growth, Datavault AI Inc. posted the faster year-over-year revenue change (3649.6% vs 7.0%). Over the past eight quarters, Datavault AI Inc.'s revenue compounded faster (1051.7% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Datavault AI Inc develops AI-powered data management and integration solutions, serving enterprise clients across the United States and North America. Its offerings help organizations unify disparate data assets, streamline analytics workflows, and accelerate machine learning model development and deployment.

AMRN vs DVLT — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.3× larger
AMRN
$45.1M
$33.8M
DVLT
Growing faster (revenue YoY)
DVLT
DVLT
+3642.6% gap
DVLT
3649.6%
7.0%
AMRN
Higher net margin
DVLT
DVLT
25.2% more per $
DVLT
2.0%
-23.3%
AMRN
Faster 2-yr revenue CAGR
DVLT
DVLT
Annualised
DVLT
1051.7%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
DVLT
DVLT
Revenue
$45.1M
$33.8M
Net Profit
$-10.5M
$661.0K
Gross Margin
89.3%
Operating Margin
12.3%
Net Margin
-23.3%
2.0%
Revenue YoY
7.0%
3649.6%
Net Profit YoY
33.0%
110.4%
EPS (diluted)
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
DVLT
DVLT
Q1 26
$45.1M
Q4 25
$49.2M
$33.8M
Q3 25
$49.7M
$2.9M
Q2 25
$72.7M
$1.7M
Q1 25
$42.0M
$629.0K
Q4 24
$62.3M
$902.0K
Q3 24
$42.3M
$1.2M
Q2 24
$67.5M
$345.0K
Net Profit
AMRN
AMRN
DVLT
DVLT
Q1 26
$-10.5M
Q4 25
$-1.2M
$661.0K
Q3 25
$-7.7M
$-33.0M
Q2 25
$-14.1M
$-37.1M
Q1 25
$-15.7M
$-9.6M
Q4 24
$-48.6M
Q3 24
$-25.1M
$-5.1M
Q2 24
$1.5M
$-42.7M
Gross Margin
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
47.1%
89.3%
Q3 25
44.7%
3.3%
Q2 25
69.2%
2.0%
Q1 25
59.8%
11.0%
Q4 24
-15.4%
24.6%
Q3 24
38.5%
19.3%
Q2 24
63.4%
3.2%
Operating Margin
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
-12.9%
12.3%
Q3 25
-22.4%
-508.1%
Q2 25
-22.0%
-718.1%
Q1 25
-39.9%
-1499.4%
Q4 24
-84.3%
Q3 24
-59.5%
-447.4%
Q2 24
-0.8%
-1566.7%
Net Margin
AMRN
AMRN
DVLT
DVLT
Q1 26
-23.3%
Q4 25
-2.5%
2.0%
Q3 25
-15.6%
-1135.5%
Q2 25
-19.4%
-2139.3%
Q1 25
-37.4%
-1520.3%
Q4 24
-78.0%
Q3 24
-59.4%
-434.5%
Q2 24
2.3%
-12366.7%
EPS (diluted)
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
$0.00
$0.53
Q3 25
$-0.02
$-0.33
Q2 25
$-0.03
$-0.54
Q1 25
$-0.04
$-0.18
Q4 24
$-0.12
Q3 24
$-0.06
$-1.39
Q2 24
$0.00
$-11.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
DVLT
DVLT
Cash + ST InvestmentsLiquidity on hand
$307.8M
$2.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$238.0M
Total Assets
$645.8M
$274.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
DVLT
DVLT
Q1 26
$307.8M
Q4 25
$302.6M
$2.0M
Q3 25
$286.6M
$1.7M
Q2 25
$298.7M
$662.0K
Q1 25
$281.8M
$171.0K
Q4 24
$294.2M
$3.3M
Q3 24
$305.7M
$3.9M
Q2 24
$306.7M
$6.1M
Stockholders' Equity
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
$459.3M
$238.0M
Q3 25
$458.9M
$99.5M
Q2 25
$464.9M
$74.1M
Q1 25
$473.7M
$81.7M
Q4 24
$486.2M
$85.7M
Q3 24
$531.4M
$4.3M
Q2 24
$551.9M
$6.4M
Total Assets
AMRN
AMRN
DVLT
DVLT
Q1 26
$645.8M
Q4 25
$670.8M
$274.7M
Q3 25
$659.8M
$138.7M
Q2 25
$670.1M
$120.7M
Q1 25
$655.7M
$95.7M
Q4 24
$685.3M
$100.6M
Q3 24
$750.6M
$8.0M
Q2 24
$799.9M
$10.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
DVLT
DVLT
Operating Cash FlowLast quarter
$-406.0K
Free Cash FlowOCF − Capex
$-734.0K
FCF MarginFCF / Revenue
-2.2%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
-0.61×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
$15.3M
$-406.0K
Q3 25
$-12.7M
$-10.4M
Q2 25
$16.6M
$-6.8M
Q1 25
$-12.5M
$-6.0M
Q4 24
$-13.3M
$-17.5M
Q3 24
$-2.4M
$-4.2M
Q2 24
$-2.7M
$-5.5M
Free Cash Flow
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
$-734.0K
Q3 25
Q2 25
Q1 25
$-6.1M
Q4 24
$-17.6M
Q3 24
$-4.2M
Q2 24
$-5.5M
FCF Margin
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
-2.2%
Q3 25
Q2 25
Q1 25
-966.0%
Q4 24
-1946.9%
Q3 24
-361.7%
Q2 24
-1599.7%
Capex Intensity
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
1.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
8.3%
Q4 24
3.9%
Q3 24
0.7%
Q2 24
4.1%
Cash Conversion
AMRN
AMRN
DVLT
DVLT
Q1 26
Q4 25
-0.61×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

DVLT
DVLT

Eos Technology Holdings Inc.$30.0M89%
Consumer Audio Products Components And Other Revenue Net$3.2M9%

Related Comparisons